NCT06612827招募中不适用
Development of Tumor Organoids From Undifferentiated Primary Carcinomas to Guide Therapeutic Decisions
Centre Francois Baclesse1 个研究点 分布在 1 个国家目标入组 20 人开始时间: 2025年3月5日最近更新:
适应症
试验速览
- 阶段
- 不适用
- 状态
- 招募中
- 发起方
- 入组人数
- 20
- 试验地点
- 1
- 主要终点
- Rate of establishment of exploitable tumor organoids
研究概览
简要总结
The study is based on the constitution of a collection of tumor and blood samples for the development of tumoroid for functional tests to predict clinical response to treatment.
研究设计
- 研究类型
- Observational
- 观察模型
- Cohort
- 时间视角
- Prospective
入排标准
- 年龄范围
- 18 Years 至 —（Adult, Older Adult）
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- •Patient with undifferentiated primary carcinoma (UPC) with histological and immunohistochemical evidence, validated in a local and/or national UPC multidisciplinary consultation
- •Patient with indication for systemic 1st-line treatment at the time of inclusion. Treatment may already have begun at the time of inclusion, but within the limit of 2 treatment cycles administered.
- •Patient with life expectancy greater than 3 months
- •Patient of legal age
- •Patient affiliated to a social security scheme
- •Signature of informed consent prior to any specific study procedure
排除标准
- •Persons deprived of their liberty or under guardianship (including curatorship)
- •Pregnant or breast-feeding patient
结局指标
主要结局
Rate of establishment of exploitable tumor organoids
时间窗: through study completion, an average of 3 years
Rate of establishment usable tumor organoids for predictive tests of response to treatment.
次要结局
未报告次要终点
研究者
研究点 (1)
Loading locations...
相似试验
招募中
不适用
Collection of Endometrial Cancer-derived Organoids to Evaluate the Efficacy of PARP Inhibitors: PENDOR Pilot StudyEndometrial CancerNCT06603506Centre Francois Baclesse16
终止
不适用
Organoids From Metastases of Prostate CancerProstatic NeoplasmNCT03952793Centre Antoine Lacassagne1
已完成
不适用
Generation of circulating tumor cell derived organoidsthrough enrichment by leukapheresis - A novel drug screening system in metastatic prostate cancerProstate cancerCRPCHSPCMetastatic prostate cancerNL-OMON29626Eramus Medical Center Rotterdam46
已完成
不适用
Prospective Primary Human Lungcancer Organoids to Predict Treatment ResponseLung CancerNCT04859166Maastricht Radiation Oncology10
暂停
不适用
Upper GI Serial Tumour BiopsiesOesophageal CancerGastric CancerNCT05233007The Christie NHS Foundation Trust300